← Open Payments lookup

CARYN CHASANOV: Open Payments

NPI 1992021687 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,739 in 130 payments from 36 companies in 2025. Trend: 2023 $2,906 · 2024 $2,534 · 2025 $3,739

Food & beverage: $3,539Education: $200
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP23$783
Actelion Pharmaceuticals US, Inc.8$295
GENZYME CORPORATION12$231
HARMONY BIOSCIENCES LLC6$228
Merck Sharp & Dohme LLC4$203
Novo Nordisk Inc7$181
GlaxoSmithKline, LLC.10$154
Axsome Therapeutics, Inc.2$149
SANOFI-AVENTIS U.S. LLC2$124
Verona Pharma, Inc.6$111

Products named: DUPIXENT, FASENRA, WAKIX, OPSUMIT, WINREVAIR, BREZTRI, TEZSPIRE, Sunosi.

Industry payments across DE — which companies pay providers there.